MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells - Wikidata - wikimedia - TriplyDB

MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells

MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells

http://www.wikidata.org/entity/Q34227586

about

Regulation of Bim in Health and Disease Reactivating p53 functions by suppressing its novel inhibitor iASPP: a potential therapeutic opportunity in p53 wild-type tumors MicroRNA-101 is a potential prognostic indicator of laryngeal squamous cell carcinoma and modulates CDK8 MicroRNA-101 suppresses migration and invasion via targeting vascular endothelial growth factor-C in hepatocellular carcinoma cells The Regulatory Role of MicroRNAs in EMT and Cancer Upregulation of miR-101 enhances the cytotoxic effect of anticancer drugs through inhibition of colon cancer cell proliferation.Epithelial-to-Mesenchymal Transition in the Female Reproductive Tract: From Normal Functioning to Disease Pathology.Role of EZH2 in cancer stem cells: from biological insight to a therapeutic target.The impact of microRNA-mediated PI3K/AKT signaling on epithelial-mesenchymal transition and cancer stemness in endometrial cancer.MicroRNA-181a is involved in the regulation of human endometrial stromal cell decidualization by inhibiting Krüppel-like factor 12 Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma.MiR-101 reverses the hypomethylation of the LMO3 promoter in glioma cells.microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer.Cyclooxygenase-2, a Potential Therapeutic Target, Is Regulated by miR-101 in Esophageal Squamous Cell Carcinoma.MicroRNA-101 is repressed by EZH2 and its restoration inhibits tumorigenic features in embryonal rhabdomyosarcoma.Differential miRNA expressions in peripheral blood mononuclear cells for diagnosis of lung cancer.Alcohol-dysregulated miR-30a and miR-934 in head and neck squamous cell carcinoma MicroRNA-101 inhibits cell progression and increases paclitaxel sensitivity by suppressing MCL-1 expression in human triple-negative breast cancer.MicroRNA-101-3p suppresses cell proliferation, invasion and enhances chemotherapeutic sensitivity in salivary gland adenoid cystic carcinoma by targeting Pim-1.MicroRNA-101 has a suppressive role in osteosarcoma cells through the targeting of c-FOS.miR-101 reverses hypomethylation of the PRDM16 promoter to disrupt mitochondrial function in astrocytoma cells The Polycomb Group Protein EZH2 Impairs DNA Damage Repair Gene Expression in Human Uterine Fibroids Autophagy inhibition of hsa-miR-19a-3p/19b-3p by targeting TGF-β R II during TGF-β1-induced fibrogenesis in human cardiac fibroblasts.MicroRNA-495 downregulates FOXC1 expression to suppress cell growth and migration in endometrial cancer.The correlation between microRNA490-3p and TGFα in endometrial carcinoma tumorigenesis and progression.MicroRNA-340 Inhibits Tumor Cell Proliferation and Induces Apoptosis in Endometrial Carcinoma Cell Line RL 95-2.Suppression of iASPP-dependent aggressiveness in cervical cancer through reversal of methylation silencing of microRNA-124.Downregulation of miR-101 contributes to epithelial-mesenchymal transition in cisplatin resistance of NSCLC cells by targeting ROCK2.EZH2 inhibition suppresses endometrial cancer progression via miR-361/Twist axis.iASPP induces EMT and cisplatin resistance in human cervical cancer through miR-20a-FBXL5/BTG3 signaling.Enhancer of Zeste homolog 2 (EZH2) induces epithelial-mesenchymal transition in endometriosis.The role of microRNAs in the pathogenesis of endometrial cancer: a systematic review.miR-29s: a family of epi-miRNAs with therapeutic implications in hematologic malignancies.Clinical translation for endometrial cancer stem cells hypothesis.The role of miRNAs in the pheochromocytomas.MiR-542-5p is a negative prognostic factor and promotes osteosarcoma tumorigenesis by targeting HUWE1.Genetic and epigenetic alterations of microRNAs and implications for human cancers and other diseases.Reactivation of epigenetically silenced miR-124 reverses the epithelial-to-mesenchymal transition and inhibits invasion in endometrial cancer cells via the direct repression of IQGAP1 expression.The future therapy of endometrial cancer: microRNA's functionality, capability, and putative clinical application.Differential expression of ten-eleven translocation genes in endometrial cancers.

P2860

Q26781203-86240DDE-DFA7-49F2-820A-826F391E51F1 Q26783710-AC9A483A-3F0C-40B6-A35C-61DEAD3D24BA Q28266383-B6AB40CD-3A74-4BAA-A2EE-86E9A74EA632 Q28273264-97061173-60E9-4C09-95F8-1638E890FE65 Q28391426-7FDA4CAA-B496-47AB-BA19-EF0E9A3AA530 Q33858033-16E7C445-9B36-4697-A37E-3AEFB61B28A6 Q33872622-CCD44089-BC7C-4785-BB75-4912734EDC67 Q33914216-7498C4EC-04FC-4B59-8128-C095405BBE45 Q34091442-780AA729-F3D2-41C0-A7E6-BBF3B8A16C99 Q35232769-99C08DD2-EBCC-40DD-A4B9-21596959E75A Q35781438-4CDE69EA-6946-4466-905A-66C484E6FB75 Q35781470-E9FF0E0E-1E2D-4A17-ADC4-A0C1BF893FBF Q35793647-844F41D6-5039-4C5D-A3D9-8C8BDD584BA8 Q35838020-44430591-4AEB-41D4-879F-EF698B6D497B Q35922940-DF4DB143-6E5C-4CB3-9781-22B2FFAD13C4 Q36101421-EC360853-00CE-4E42-9122-0D90103D1DC4 Q36168885-CFE51F1F-B961-4E7F-BCE1-2E35F090FE99 Q36299580-349924B8-FC17-4558-BFED-C4BCB5DC3B02 Q36309379-B0C7FCB4-D457-4729-8CB6-F008A40C4BB0 Q36742322-0DDA2868-0FCE-4DFE-94B0-8C9E58B608B0 Q36782656-84D7E5D5-7BE4-47CC-BA23-9E648C03ACF1 Q36791100-BD5104AB-89FE-4017-A795-F431C7C9103B Q36819566-0BDB4913-9865-413C-B8AB-FFDF38FD5629 Q36827700-FB0D501E-8D8A-4F0A-9C55-DF79A9F344B1 Q36962563-0E75D03A-91CB-46B3-B4C0-C8FC5466A2A2 Q37029456-8A67F659-270C-4673-AA15-A8F3BFA870CD Q37355325-CFB50604-898E-4EC1-8628-EADA543B4108 Q37437206-FD7220A7-E004-424A-AA0F-6DCBAC5414F9 Q37706651-C720B8C0-F9AA-4CFD-A7AF-5A1CC3DE5FAB Q37748056-1333C407-419C-4504-B5E2-01DF8C023D7C Q38287628-443E3F43-B8F1-4DC3-8A17-59FCB8BE0CE6 Q38362213-B674B16D-1357-4461-B68C-1A2254E2AD27 Q38476564-A89A68BF-DFE9-495A-AAA9-59D8E56695F5 Q38557171-D06B0798-781A-474A-A84C-7DB36476BC6E Q38606234-BABD2868-1E35-46C7-B3B2-A6DCC6FB8700 Q38631882-2CCA8C69-6DB7-44F7-88BF-C506652E480D Q38664137-55BD8324-8183-4880-AEFB-41BA1B2026B2 Q38789702-99EEEE0C-5B8F-4F32-BF5E-2D9A42910827 Q38820391-0B9006EA-5E01-4FEF-95D6-4E19BD9A9BAA Q38871612-87EAA237-DEDA-437A-B834-CB1E20EA0EA2

P2860

MicroRNA-101 targets EZH2, MCL-1 and FOS to suppress proliferation, invasion and stem cell-like phenotype of aggressive endometrial cancer cells

http://www.wikidata.org/entity/Q34227586

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

MicroRNA-101 targets EZH2, MCL ...... ssive endometrial cancer cells

@ast

MicroRNA-101 targets EZH2, MCL ...... ssive endometrial cancer cells

@en

MicroRNA-101 targets EZH2, MCL ...... ssive endometrial cancer cells

@nl

type

label

MicroRNA-101 targets EZH2, MCL ...... ssive endometrial cancer cells

@ast

MicroRNA-101 targets EZH2, MCL ...... ssive endometrial cancer cells

@en

MicroRNA-101 targets EZH2, MCL ...... ssive endometrial cancer cells

@nl

prefLabel

MicroRNA-101 targets EZH2, MCL ...... ssive endometrial cancer cells

@ast

MicroRNA-101 targets EZH2, MCL ...... ssive endometrial cancer cells

@en

MicroRNA-101 targets EZH2, MCL ...... ssive endometrial cancer cells

@nl

P1433

Q34227586-361B4228-FCCE-40F0-BF98-0F4CB69C96BE

P1476

Q34227586-3D6D7C78-9DD2-4735-A311-66C3694E7FA2

P2093

Q34227586-09C3A934-DE8E-45EB-A845-6D69B7FEB96B

Q34227586-32430830-33DE-423A-A009-A98C0F14C562

Q34227586-3C232A54-9B24-480D-9EA8-F55C39A0B531

Q34227586-7AE7BACF-6AD7-486C-8DD0-178FB2557ECB

Q34227586-7D28CC9C-8D3C-44EF-ADEB-51352504A75F

Q34227586-85025E82-E8C0-4595-9B0F-B7BED29A7D13

Q34227586-9F65A8F4-260A-4FF4-B05E-2CDD4816D3A5

Q34227586-F043F2C2-C6DA-425A-B40B-C85223AD9BEE

Q34227586-F7C6709D-9492-4BA4-85E4-B56CE208D595

Q34227586-F9A190AE-2087-4D45-962B-2A494ED0F9D2

P2860

Q34227586-029891A3-3CA3-4852-AFC9-41C7F7D0B1D0

Q34227586-07D488E4-6A63-487F-A59C-EBBEFC006302

Q34227586-0E997EE1-D2CE-4A9D-873A-2EFEEE4134EF

Q34227586-110DC59C-0151-40A9-A779-190890A64D3C

Q34227586-12CF3BE5-4F13-4DF4-BD04-8FB3B8B349DE

Q34227586-14A2A1CA-0BC7-4B66-99A1-EBA813FC266F

Q34227586-17BE051D-767D-4F3F-87A3-A02CAEF31805

Q34227586-18B7557F-9F04-415A-BA91-6010F2EFFEDA

Q34227586-1B814F10-DACF-4C63-A48A-9145FD7A7B52

Q34227586-1C3107D9-55D3-4FD0-9B80-F7DA89FA382C

P304

Q34227586-D5EA5A2B-B5BD-4AF6-9567-0380192F7788

P31

Q34227586-478226A5-AA52-4087-B7A2-C42AC6AB5232

P356

Q34227586-452952C3-F1EE-42C3-AA92-48BA3B50AB0F

P407

Q34227586-12A94A5C-9810-4B43-8E46-B67ED0312078

P433

Q34227586-6BCC267A-059F-4103-8F9E-21CB6AABFC21

P478

Q34227586-DF524F57-BCC8-495A-91DA-06DDEC1C9154

P50

Q34227586-00817378-171E-4687-AAEF-459F7BAF01A9

Q34227586-443F08BB-8289-4285-89E6-2B3A1161006E

P577

Q34227586-5A9CD443-2324-4E08-9FF6-EA66CE0B2666

P5875

Q34227586-D43A26D6-8B4E-4AE2-8D80-BBF56A698F14

P698

Q34227586-FA95AB46-9BCF-4EE3-B48C-3994CE824A63

P921

Q34227586-FA97035E-F4C7-4D01-A830-B845F076576B

P932

Q34227586-5E627E4C-0B89-4874-AFAB-193D43D8FCDA

P356

ONCOTARGET.2157

P1433

P1476

MicroRNA-101 targets EZH2, MCL ...... ssive endometrial cancer cells

@en

P2093

Fumihiko Suzuki

http://www.w3.org/2001/XMLSchema#string

Hidemichi Watari

http://www.w3.org/2001/XMLSchema#string

Jiabin Lu

http://www.w3.org/2001/XMLSchema#string

Masataka Kudo

http://www.w3.org/2001/XMLSchema#string

Masayoshi Hosaka

http://www.w3.org/2001/XMLSchema#string

Muyan Cai

http://www.w3.org/2001/XMLSchema#string

Sharon J B Hanley

http://www.w3.org/2001/XMLSchema#string

Takashi Mitamura

http://www.w3.org/2001/XMLSchema#string

Ying Xiong

http://www.w3.org/2001/XMLSchema#string

Yosuke Konno

http://www.w3.org/2001/XMLSchema#string

P2860

MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1

A microRNA expression signature of human solid tumors defines cancer gene targets

The estrogen-dependent c-JunER protein causes a reversible loss of mammary epithelial cell polarity involving a destabilization of adherens junctions

Emerging therapeutic biomarkers in endometrial cancer

Regulation of mesenchymal phenotype by MicroRNAs in cancer

Targeting Mcl-1 for the therapy of cancer

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth

EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer

miRNAs, cancer, and stem cell division

P304

6049-6062

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.2157

http://www.w3.org/2001/XMLSchema#string

P407

P433

15

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263863228

http://www.w3.org/2001/XMLSchema#string

P698

25153722

http://www.w3.org/2001/XMLSchema#string

P921

P932

4171612

http://www.w3.org/2001/XMLSchema#string